Supplementary material The Supplementary Material for this article can be found online at: Supplementary Table 1 Clinical characteristics and laboratory findings of study participants at baseline and 12 months after GLP-1 receptor agonist initiation
Chronic kidney disease promotes cerebral microhemorrhage formation
doi: 10.1016/j.phymed.2013.04.019 36 ChiLGaoWShuXLuX
N Engl J Med 372(23):21972206 Hernandez AF, Green JB, Janmohamed S, DAgostino RB Sr, Granger CB, Jones NP, Harmony Outcomes committees and investigators et al (2018) Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovasculardisease (Harmony outcomes): a double-blind, randomised placebo-controlled trial
It attenuates but remains above background
Frontiers in Medicine, 9 , 1077275